BioCentury | Jul 13, 2018
Financial News

Nextbiotix raises EUR7M series A round to bring IBD therapy into clinic

...million) in a series A round led by new investor Auriga Partners. Fellow new investors Sofimac...
BioCentury | Jul 5, 2018
Financial News

Nextbiotix raises €7M series A for microbiome-based therapy

...France) raised €7 million ($8.1 million) in a series A round led by Auriga Partners. Sofimac...
...in preclinical testing for Crohn's disease, ulcerative colitis and irritable bowel syndrome (IBS). Allison Johnson Auriga Partners Cap Innov'Est Sofimac Laboratoires...
BioCentury | Nov 9, 2015
Financial News

ElsaLys Biotech completes venture financing

...Antibodies, Cancer, Inflammation Date completed: 2015-11-03 Type: Venture financing Raised: EUR2.7 million ($3 million) Investors: Sofimac...
BioCentury | Mar 23, 2015
Financial News

Alize Pharma completes venture financing

...France Business: Endocrine/Metabolic Date completed: 2015-03-17 Type: Venture financing Raised: EUR1.8 million ($1.9 million) Investors: Sofimac...
BioCentury | Mar 23, 2015
Finance

Alize's assets

...to develop osteoporosis peptide I-HBD1, raised €1.8 million ($1.9 million) in seed financing. Investors included Sofimac...
BioCentury | Jul 29, 2013
Financial News

Crossject completes venture financing

...Drug delivery Date completed: 6/28/13 Type: Venture financing Raised: $6 million Investors: A Plus Finance; Sofimac...
BioCentury | May 20, 2013
Financial News

ElsaLys Biotech completes venture financing

...Date completed: 5/17/13 Type: Venture financing Raised: €2.1 million ($2.7 million) Investors: Transgene S.A. ; Sofimac WIR...
BioCentury | Jul 26, 2010
Finance

Bear out of Hibernation

...€28.5 million from a group of French VCs including Comex, Innoveris, SGAM, Turenne Capital Partenaire, Sofimac...
BioCentury | Mar 5, 2007
Strategy

Trans-Atlantic play

...he said. Thus, OPi's investors have made at least six times their investment. Shareholders include Sofimac...
BioCentury | Mar 8, 2004
Emerging Company Profile

Corporate Profile

...Employees: 32 Funds raised: E12 million ($15.2 million) Investors: Comex; Innoveris; SGAM; Turenne Capital Partenaire; Sofimac...
Items per page:
1 - 10 of 13
BioCentury | Jul 13, 2018
Financial News

Nextbiotix raises EUR7M series A round to bring IBD therapy into clinic

...million) in a series A round led by new investor Auriga Partners. Fellow new investors Sofimac...
BioCentury | Jul 5, 2018
Financial News

Nextbiotix raises €7M series A for microbiome-based therapy

...France) raised €7 million ($8.1 million) in a series A round led by Auriga Partners. Sofimac...
...in preclinical testing for Crohn's disease, ulcerative colitis and irritable bowel syndrome (IBS). Allison Johnson Auriga Partners Cap Innov'Est Sofimac Laboratoires...
BioCentury | Nov 9, 2015
Financial News

ElsaLys Biotech completes venture financing

...Antibodies, Cancer, Inflammation Date completed: 2015-11-03 Type: Venture financing Raised: EUR2.7 million ($3 million) Investors: Sofimac...
BioCentury | Mar 23, 2015
Financial News

Alize Pharma completes venture financing

...France Business: Endocrine/Metabolic Date completed: 2015-03-17 Type: Venture financing Raised: EUR1.8 million ($1.9 million) Investors: Sofimac...
BioCentury | Mar 23, 2015
Finance

Alize's assets

...to develop osteoporosis peptide I-HBD1, raised €1.8 million ($1.9 million) in seed financing. Investors included Sofimac...
BioCentury | Jul 29, 2013
Financial News

Crossject completes venture financing

...Drug delivery Date completed: 6/28/13 Type: Venture financing Raised: $6 million Investors: A Plus Finance; Sofimac...
BioCentury | May 20, 2013
Financial News

ElsaLys Biotech completes venture financing

...Date completed: 5/17/13 Type: Venture financing Raised: €2.1 million ($2.7 million) Investors: Transgene S.A. ; Sofimac WIR...
BioCentury | Jul 26, 2010
Finance

Bear out of Hibernation

...€28.5 million from a group of French VCs including Comex, Innoveris, SGAM, Turenne Capital Partenaire, Sofimac...
BioCentury | Mar 5, 2007
Strategy

Trans-Atlantic play

...he said. Thus, OPi's investors have made at least six times their investment. Shareholders include Sofimac...
BioCentury | Mar 8, 2004
Emerging Company Profile

Corporate Profile

...Employees: 32 Funds raised: E12 million ($15.2 million) Investors: Comex; Innoveris; SGAM; Turenne Capital Partenaire; Sofimac...
Items per page:
1 - 10 of 13